UPDATE: Oppenheimer Starts Aquestive Therapeutics (AQST) at Outperform
Tweet Send to a Friend
(Updated - September 6, 2022 4:04 PM EDT)
Oppenheimer analyst Francois Brisebois initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Francois Brisebois initiates coverage on Aquestive Therapeutics (NASDAQ: AQST) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
